Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: Jim Bishop who wrote (28872)	2/18/2000 9:51:00 AM
From: SSP	Read Replies (2) \| Respond to of 150070

KAHI - Kaire Holdings Inc. and Stason Pharmaceuticals Inc. to Merge Certain Assets in Two New Public Companies LOS ANGELES, Feb 18, 2000 (BUSINESS WIRE) -- Kaire Holdings Inc. (OTCBB:KAHI), an emerging developer of pure-play Internet initiatives, announced that it has formed a strategic business relationship with Stason Pharmaceuticals Inc. ("Stason"), the U.S. affiliate of Taiwan-based Standard Chemical and Pharmaceutical Co. Limited. Stason is an FDA-approved manufacturer of pharmaceutical drugs as well as various over-the-counter, health-oriented consumer products. Stason also provides certain laboratory services to companies engaged in the research and development of pharmaceutical drugs. Stason operates from its 37,000-square-foot Irvine, Calif., facility that contains research and development laboratories as well as facilities for testing product stability and filling. The Stason Irvine facility is located near the main UPS Irvine hub. Under the agreement, Stason will acquire a minority interest in YesRx.com. The terms of the agreement require that Stason pay Kaire an undisclosed sum of cash, and in conjunction with Kaire, build a new state-of-the-art YesRx.com fulfillment center at Stason's facility. YesRx.com will continue to be guided by its current management team from the Kaire corporate headquarters. Stason will also acquire a majority interest in Kaire's EZ-Trac laboratory division while contributing their similar business. Kaire's laboratory technicians are currently training a team of Stason technicians. That training will be completed in May of this year. At that time the EZ-Trac laboratory will be relocated to a new laboratory at the Stason facility. Stason will assume control of the business at that time. Upon completion of the YesRx.com fulfillment center and the relocation of the EZ-Trac laboratory business, Kaire will spin-off to its shareholders its YesRx.com e-commerce Internet pharmacy and also its EZ-Trac laboratory business, thereby creating two new public entities. Full details, including the stock distribution, remain to be determined. Kaire and its financial advisors will release that information as soon as it's available. Kaire CEO Steven Westlund commented: "We are very excited about the relationship with Stason. They are a well-respected company with a global presence and successful track record. This agreement will enable YesRx.com to better serve its customers through economies of scale and efficient high-quality customer service. "In addition, the combined EZ-Trac and Stason laboratory businesses will provide for expanded services to its customers. Further, the spin-offs allow Kaire to continue executing its business plan as an Internet incubator while simultaneously benefiting current Kaire shareholders." Westlund added: "The YesRx advertising campaign is scheduled to start on or about February 24, 2000, utilizing network affiliated radio stations. That campaign will begin in the Los Angeles market through a CBS affiliate station. YesRx will make that commercial available for replay at its YesRx.com Web site." About Kaire Kaire is an emerging developer of pure-play Internet initiatives. Kaire launched YesRx.com, its first e-commerce Internet company, in May 1999. YesRx.com is an Internet-based provider of health, beauty and wellness products, content and health-related services on the World Wide Web. Kaire believes strongly in the future of the Internet and is committed to developing innovative Internet companies that provide effective solutions combined with the strongest possible content. This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). In particular when used in the preceding discussion, the words "plan," "confident that," "believe," "expect," "intend to" and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to risks and uncertainties, and actual results could differ materially from those expressed in any forward-looking statements. Such risks and uncertainties include, but are not limited to, market conditions, competitive factors, the ability to successfully complete additional financings and other risks. Copyright (C) 2000 Business Wire. All rights reserved. Distributed via COMTEX. -0- CONTACT: Kaire Holdings Inc., North Hollywood Steve Westlund, 818/255-4996 818/255-4997 (fax) e-mail@vitaplanet.com